How Novo Integrated Sciences Inc. (NVOS) Works From A Technical Perspective

Novo Integrated Sciences Inc. (NASDAQ:NVOS) finished Thursday with a subtraction of -$0.02 to close at $0.18, a downside of -9.00 percent. An average of 95,607,297 shares of common stock have been traded in the last five days. There was a gain of $0.0295 in the past week, and it reached a new high 2 times over the past 12 months. The last 20 days have seen an average of 64,857,063 shares traded, while the 50-day average volume stands at 28,115,227.

NVOS stock has increased by 47.97% in the last month. The company shares reached their 1-month lowest point of $0.0690 on 08/14/23. With the stock rallying to its 52-week high on 01/09/23, shares of the company touched a low of $0.07 and a high of $1.79 in 52 weeks. It has reached a new high 2 times so far this year and lost -9.50% or -$0.0191 in price. In spite of this, the price is down -89.83% from the 52-week high.

Top 5 AI Stocks to Buy for 2023

The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything. According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.

Click Here to Download the FREE Report.

Sponsored

Valuation Metrics

Novo Integrated Sciences Inc. (NVOS) stock’s beta is -0.39. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 23.76, the price-to-book (PB) ratio at 0.96.

Financial Health

The quick ratio of Novo Integrated Sciences Inc. for the recent quarter was 0.50, and the current ratio was 0.60, indicating that the company is not able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.09 for the recent quarter. Novo Integrated Sciences Inc.’s EBITDA margin is -55.95%. Its gross profit as reported stood at $4.8 million compared to revenue of $11.74 million.

Earnings Surprise

In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$1.5 million in the quarter, while revenues of -$3.94 million were shrunk -220.67%. Shareholders own equity worth $148.43 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at Novo Integrated Sciences Inc. (NVOS) price momentum. RSI 9-day as of the close on 24 August was 63.29%, suggesting the stock is Neutral, with historical volatility in this time frame at 374.65%.

As of today, NVOS’s price is $0.1767 +19.34% or $0.0295 from its 5-day moving average. NVOS is currently trading +62.79% higher than its 20-day SMA and +48.21% higher than its 100-day SMA. However, the stock’s current price level is +37.05% above the SMA50 and -34.74% below the SMA200.

The stochastic %K and %D were 67.44% and 62.80%, respectively, and the average true range (ATR) was 0.0443. With the 14-day stochastic at 62.47% and the average true range at 0.0355, the RSI (14) stands at 61.85%. The stock has reached 0.0350 on the 9-day MACD Oscillator while the 14-day reading was at 0.0602.

Most Popular

Related Posts